Serum PDGF-AB in pleural mesothelioma

Tumor Biology

Volumn 26, Issue 5, 2005, Pages 221-226

  Filiberti, Rosa ^a   Marroni, Paola ^a   Neri, Monica ^a   Ardizzoni, Andrea ^a   Betta, Pier Giacomo ^b   Cafferata, Mara A ^a   Canessa, Pier Aldo ^c   Puntoni, Riccardo ^a   Ivaldi, Giovanni Paolo ^d   Paganuzzi, Michela ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Pathology Unit   (Italy)

^c Ospedale S Bartolomeo   (Italy)

^d Pneumology   (Italy)

Author keywords

Asbestos; Biomarker; Growth factor; PDGF; Pleural mesothelioma; Prognosis; Serum

Indexed keywords

ASBESTOS; BIOLOGICAL MARKER; PLATELET DERIVED GROWTH FACTOR AB;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SMALL CELL CANCER; MALE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; TIME SERIES ANALYSIS;

EID: 24144456982     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087376     Document Type: Article

References (31)

1. Baas P: Predictive and prognostic factors in malignant pleural mesothelioma. Curr Opin Oncol 2003;15:127-130.
2. Antoniades HN, Galanopoulos T, Neville-Golden J, O'Hara CJ: Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products. Proc Natl Acad Sci USA 1992;89:3942-3946.
3. Westermark B, Heldin CH: Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth. Acta Oncol 1993;32:101-105.
4. Kawai T, Hiroi S, Torikata C: Expression in lung carcinomas of platelet-derived growth factor and its receptors. Lab Invest 1997;77:431-436.
5. Betsholtz C, Karlsson L, Lindahl P: Developmental roles of platelet-derived growth factors. Bioassays 2001;3:494-507.
6. Safi A, Sadmi M, Martinet N, Menard O, Vaillant P, Gallati H, Hosang M, Martinet Y: Presence of elevated levels of platelet-derived growth factor (PDGF) in lung adenocarcinoma pleural effusions. Chest 1992;102:204-207.
7. Soderdahl G, Betsholtz C, Johansson A, Nilsson K, Bergh J: Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small cell human lung carcinoma lines. Int J Cancer 1988;41:636-641.
8. Ascoli V, Scalzo CC, Facciolo F, Nardi F: Platelet-derived growth factor receptor immunoreactivity in mesothelioma and nonneoplastic mesothelial cells in serous effusions. Acta Cytol 1995;39:613-622.
9. Prins JB, Langerak AW, Dirks RP, Van Der Linden, Van Beurden CA DeLaat PA, Bloemers HP, Versnel MA: Identification of regulatory sequences in the promoter of the PDGF B-chain gene in malignant mesothelioma cell lines. Biochim Biophys Acta 1996;317:223-232.
10. Seifert RA, van Koppen A, Bowen-Pope DF: PDGF-AB requires PDGF receptor alpha-sub-units for high-affinity, but not for low-affinity, binding and signal transduction. J Biol Chem 1993;268:4473-4480.
11. Coats SR, Love HD, Pledger WJ: Platelet-derived growth factor (PDGF)-AB-mediated phosphorylation of PDGF beta receptors. Biochem J 1994;297:379-384.
12. Langerak AW, De Laat PA, Van der Linden-Van Beurden CA, Delahaye M, Van Der Kwast TH, Hoogsteden HC, Benner R, Versnel MA: Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo. J Pathol 1996;178:151-160.
13. Steele JPC: Prognostic factors in mesothelioma. Semin Oncol 2002;29:36-40.
14. Brandt-Kauf PW, Smith S, Hemminki K, Koskinen H, Vainio H, Niman H, Ford J: Serum oncoproteins and growth factors in asbestosis and silicosis patients. Int J Cancer 1992;50:881-885.
15. Antoniades H: Human platelet-derived growth factor (PDGF). Amino-terminal amino acid sequence. Science 1983;220:963-965.
16. Vignaud JM, Marie B, Klein N, Plenat F, Pech M, Borrelly J, Martinet N, Duprez A, Martinet Y: The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer. Cancer Res 1994;54:5455-5463.
17. Karlsson C, Paulsson Y: Age related induction of platelet-derived growth factor A-chain mRNA in normal human fibroblasts. J Cell Physiol 1994;158:256-262.
18. Battegay EJ, Rupp J, Iruela-Arispe L: PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol 1994;125:917-928.
19. Langerak AW, van der Linden-van Beurden CA, Versnel MA: Regulation of differential expression of platelet-derived growth factor alpha- and beta-receptor mRNA in normal and malignant human mesothelial cell lines. Biochim Biophys Acta 1996;1305:63-70.
20. Katano M, Nakamura M, Fujimoto K, Miyazaki K, Monsaki T, Mori M: Prognostic value of platelet-derived growth factor-A (PDGF-A) in gastric carcinoma. Ann Surg 1998;227:365-371.
21. Takanami I, Imamuma T, Yamamoto Y, Kodaira S: Usefulness of platelet-derived growth factor as a prognostic factor in pulmonary adenocarcinoma. J Surg Oncol 1995;58:40-43.
22. Attanoos RL, Griffin A, Gibbs AR: The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p 53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology 2003;43:231-238.
23. Ramael M, Buysse C, van den Bossche J, Segers K, Van Marck E: Immunoreactivity for the beta chain of the platelet-derived growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium. J Pathol 1992;167:1-4.
24. Metheny-Barlow LJ, Flynn B, van Gijssel HE, Marrogi A, Gerwin BI: Paradoxical effects of platelet-derived growth factor-A overexpression in malignant mesothelioma. Antiproliferative effects in vitro and tumorigenic stimulation in vivo. Am J Respir Cell Mol Biol 2001;24:694-702.
25. Ariad S, Seymour L, Bezwoda WR: Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: correlation with stage and rate of progression. Breast Cancer Res Treat 1991;20:11-17.
26. De Pangher Manzini V, Brollo A, Bianchi C: Thrombocytosis in malignant pleural mesothelioma. Tumori 1990;76:576-578.
27. Hart CE, Bailey M, Curtis DA, et al: Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry 1990;29:166-172.
28. Soma Y, Dvonch V, Grotendorst GR: Platelet-derived growth factor AA homodimer is the predominant isoform in human platelets and acute human wound fluid. FASEB J 1992;6:2996-3001.
29. Nisman B, Barak V, Heching N, Kramer M, Reinus C, Lafair J: Cytokeratin markers in malignant pleural mesothelioma. Cancer Detect Prev 1998;22:416-421.
30. Schouwink H, Korse CM, Bonfrer JM, Hart AA, Baas P: Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma. Lung Cancer 1999;25:25-32.
31. Sulzbacher I, Birner P, Traxler M, Marberger M, Haitel A: Expression of platelet-derived growth factor-alpha alpha receptor is associated with tumor progression in clear cell renal cell carcinoma. Am J Clin Pathol 2003;120:107-112.